SeaStar Medical Holding Corp (ICU)

Currency in USD
0.889
+0.089(+11.13%)
Closed·
0.890+0.001(+0.11%)
·
ICU Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ICU is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.7810.905
52 wk Range
0.3055.790
Key Statistics
Prev. Close
0.889
Open
0.8
Day's Range
0.781-0.905
52 wk Range
0.305-5.79
Volume
2.08M
Average Volume (3m)
7.67M
1-Year Change
-86.11%
Book Value / Share
0.21
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ICU Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.000
Upside
+124.97%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

SeaStar Medical Holding Corp Company Profile

SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.

SeaStar Medical Holding Corp Earnings Call Summary for Q2/2025

  • Revenue up 15% to $338,000 in Q2 2025; net loss narrows to $2 million from $3.2 million year-over-year
  • SeaStar Medical raises $12.4 million through offerings, ending quarter with $6.3 million cash and no debt
  • Quellimmune therapy launched in pediatric market; company aims to expand into adult acute kidney injury sector
  • Neutralized AKI pivotal trial completion targeted for end of 2025; PMA filing planned for 2026
  • Stock down 0.36% after-hours despite positive results; analysts maintain $7.00 price target
Last Updated: 13/08/2025, 22:18
Read Full Transcript

Compare ICU to Peers and Sector

Metrics to compare
ICU
Peers
Sector
Relationship
P/E Ratio
−1.7x−4.1x−0.6x
PEG Ratio
−0.02−0.150.00
Price/Book
7.4x3.1x2.6x
Price / LTM Sales
32.4x2.9x3.3x
Upside (Analyst Target)
125.0%40.2%39.0%
Fair Value Upside
Unlock2.7%4.9%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 2.000
(+124.97% Upside)

Earnings

Latest Release
Aug 13, 2025
EPS / Forecast
-0.18 / -0.40
Revenue / Forecast
338.00K / --
EPS Revisions
Last 90 days

ICU Income Statement

People Also Watch

49.60
BMNR
-7.27%
3.400
NCNA
-1.16%
1.940
UAVS
-1.02%
0.4451
BTOG
-8.51%
0.741
IXHL
+26.02%

FAQ

What Stock Exchange Does SeaStar Medical Holding Trade On?

SeaStar Medical Holding is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for SeaStar Medical Holding?

The stock symbol for SeaStar Medical Holding is "ICU."

What Is the SeaStar Medical Holding Market Cap?

As of today, SeaStar Medical Holding market cap is 24.93M.

What Is SeaStar Medical Holding's Earnings Per Share (TTM)?

The SeaStar Medical Holding EPS (TTM) is -2.02.

From a Technical Analysis Perspective, Is ICU a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has SeaStar Medical Holding Stock Split?

SeaStar Medical Holding has split 1 times.

How Many Employees Does SeaStar Medical Holding Have?

SeaStar Medical Holding has 19 employees.

What is the current trading status of SeaStar Medical Holding (ICU)?

As of 26 Aug 2025, SeaStar Medical Holding (ICU) is trading at a price of 0.89, with a previous close of 0.89. The stock has fluctuated within a day range of 0.78 to 0.91, while its 52-week range spans from 0.31 to 5.79.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.